Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer-Reference-Cited by-同舟云学术

Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer

Published:2017-04 Issue: Volume:32 Page:186-191
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Schrauder Michael G.,Brunel-Geuder Lisa,Häberle Lothar,Wunderle Marius,Hoyer Juliane,Reis André,Schulz-Wendtland Rüdiger,Beckmann Matthias W.,Lux Michael P.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference25 articles.

1. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer;Peto;J Natl Cancer Inst,1999

2. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies;Antoniou;Am J Hum Genet,2003

3. Cancer facts & figures 2014;American Cancer Society,2014

4. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of embrace;Mavaddat;J Natl Cancer Inst,2013

5. Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status;Haffty;Lancet,2002

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 20 Jahre „Senologie“ – Qualitätssicherung, Benchmarking und Ökonomie;Senologie - Zeitschrift für Mammadiagnostik und -therapie;2024-09

2. A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study;Gastroenterology;2024-05

3. Factors Influencing Adherence to the Risk Management Program for Women With a Genetic Predisposition to Breast Cancer: Real-World Data from a French Multicenter Program;The Oncologist;2024-04-02

4. Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience;Hereditary Cancer in Clinical Practice;2023-11-13

5. Krankheitslast von Brustkrebs in Deutschland: Epidemiologie und Kosten;Forum;2023-06-20